314841
Harmful Algal Bloom Surveillance: Defining an Emerging Environmental Health Concern
With funding from the Centers for Disease Control and Prevention, the interagency team developed case reporting pathways, including automated call notifications from the Wisconsin Poison Center, a web-based illness survey, direct contact with ill individuals, and referrals from partner agencies. Illness reports were reviewed by program staff to ensure they fit the case definition of a HAB-related illness and follow-up water sampling was conducted to determine environmental conditions at the time of the exposure.
Between 2009 and 2013, DHS received 144 health complaints associated with exposure to HABs. The most common illnesses were gastrointestinal distress, rash, respiratory irritation and cold-like symptoms. Cyanotoxins were detected in over 56% of the environmental samples analyzed.
Expanded outreach efforts to health-care professionals, veterinarians and local lake associations helped increase reporting of HAB-related illnesses and awareness of the potential hazard associated with algal blooms. The information gathered in this surveillance effort has helped the interagency team prioritize surveillance and outreach activities to address the public health burden of HABs and implement interventions to reduce exposures to harmful algal blooms.
Learning Areas:
Administer health education strategies, interventions and programsEnvironmental health sciences
Epidemiology
Learning Objectives:
Define freshwater harmful algal blooms and the potential threat they pose to public health
Identify common routes of exposure to freshwater harmful algal blooms
Describe Wisconsin's inter-agency approach to addressing freshwater harmful algal blooms
Keyword(s): Environmental Health, Water & Health
Qualified on the content I am responsible for because: I have been the primary manager for the Wisconsin Harmful Algal Blooms program since 2009. I have a masters in public health degree from the University of Wisconsin.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.